Cancer Research UK| July 2020| Cancer Patient Experience Survey 2020 The impact of COVID-19 on cancer patients in the UK
Taken from the Executive Summary
Overall for many cancer patients the COVID-19 pandemic appears to have had a significant impact on their testing and treatment, and most notably their care:
• 40 % of cancer patients surveyed reported that their testing had been impacted.
•One- third of patients surveyed reported that their treatment had been impacted.
• 2 in 3 cancer patients reported that their cancer care had been impacted.
• Ratings of overall cancer care as ‘very good’ decreased from 75% ‘before lockdown started’ to 37% ‘after lockdown started’.
• Possible significant differences in experience were found by region in England for testing, treatment and care (p less than .01).
• Possible significant differences in experience for care was flagged for social economic status (SES), nation, region and cancer type (p less than .01).
• 71% of cancer patients stated that they had been treated in the same hospital as usual, with no significant differences by SES, cancer type, nation or region.
This has resulted in a negative impact on the emotional well-being of many cancer patients:
• The most common emotions reported were ‘anxious’ and ‘frustrated’. This was consistent for all patients surveyed, those who reported to have their testing and treatment impacted, and across breakdowns (SES, nation region and cancer type).
• ‘Catching COVID-19’ and ‘becoming seriously ill from COVID-19’ were the most selected concerns, and there was a lot of frustration reported in the open text comments
Full report available from Cancer Research UK